Guidelines for Pediatric Cancer Centers
PEDIATRICSPublished 1 June 2004
Section on Hematology/Oncology
Citations89
SJR quartileQ1
SJR score2.41
SNIP2.49
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The importance of board-certified pediatric hematologists/oncologists, pediatric subspecialty consultants, and appropriately qualified pediatric medical subspecialists and pediatric surgical specialists overseeing the care of all children with cancer are emphasized.
Abstract
Since the American Academy of Pediatrics published guidelines for pediatric cancer centers in 1986 and 1997, significant changes in the delivery of health care have prompted a review of the role of tertiary medical centers in the care of pediatric patients. The potential effect of these changes on the treatment and survival rates of children with cancer led to this revision. The intent of this statement is to delineate personnel and facilities that are essential to provide state-of-the-art care for children and adolescents with cancer. This statement emphasizes the importance of board-certified pediatric hematologists/oncologists, pediatric subspecialty consultants, and appropriately qualified pediatric medical subspecialists and pediatric surgical specialists overseeing the care of all pediatric and adolescent cancer patients and the need for facilities available only at a tertiary center as essential for the initial management and much of the follow-up for pediatric and adolescent cancer patients.
Keywords
MedicineHealth Professions
CancerIncidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type
558 Citations1995James G. Gurney, Richard K. Severson +2 more
The purpose of this report is to provide histology‐specific incidence rates within single‐year age groups, stratified by sex and race, among children.
Medical and Pediatric OncologyCancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials
393 Citations2001W. Archie Bleyer
The 5-year outcome in 15-19 year olds with leukemias and sarcomas is not only worse than in younger patients, but also lower in this population at large than in patients of the same age treated at Children's Cancer Group institutions.
Archives of Disease in ChildhoodCentralisation of treatment and survival rates for cancer.
145 Citations1988Charles Stiller
Children with acute non-lymphoblastic leukaemia, non-Hodgkin's lymphoma, Ewing's tumour, rhabdomyosarcoma, and (during 1981-84) osteosarComa treated at paediatric oncology centres had significantly higher survival rates than those treated elsewhere.
Cancer InvestigationSurvival in Childhood Acute Lymphocytic Leukemia: Effect of Protocol and Place of Treatment
111 Citations1983Anna T. Meadows, Shira Kramer +4 more
Treatment according to protocol was associated with improved survival, yielding a 4 year survival of 60% vs 19% for nonprotocol treated patients, and there was also a significantly improved survival rate among patients treated in a cancer center, especially for those with a low white blood count at diagnosis.
BloodHemizygous p16INK4A deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse
92 Citations2001T. L. Carter
The study revealed, strikingly, that the risk ratio for relapse for hemizygous deletion compared with no deletion was 6.558 and that homozygous deletion of p16 in pediatric ALL patients is an independent prognostic indicator of outcome from therapy.
Journal of Clinical OncologyInfluence of place of treatment on diagnosis, treatment, and survival in three pediatric solid tumors.
89 Citations1984Sharon Kramer, Anna T. Meadows +3 more
Among medulloblastoma patients, differences were detected in the frequency of pretreatment evaluations and in the therapy used, and the principal management contrast found in rhabdomyosarcoma was that multiagent chemotherapy was used less often in NCC.
BMJNephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial.
86 Citations1979E L Lennox, Charles Stiller +2 more
All children with nephroblastoma should be treated according to well-defined protocols which take into account the age of the child and the stage of the tumour and include a full course of maintenance chemotherapy.
LeukemiaMolecular genetics in acute leukemia
84 Citations2000JD Rowley
Improved techniques in identifying the chromosome changes and the affected genes that are involved in acute leukemias have led to improved treatments for these diseases and genotype-specific therapies should be used that take into account the genetic alterations of the particular leukemia.
CancerWhat can be learned about childhood cancer from “cancer statistics review 1973–1988”
83 Citations1993W. Archie Bleyer
National data on childhood cancer is becoming more available, but there continues to be a paucity of information on which to draw conclusions about which patients should be diagnosed and treated.
Medical and Pediatric OncologyChildhood NHL in Switzerland: Incidence and Survival of 120 Study and 42 Non‐Study Patients
58 Citations1995Hans-Peter Wagner, I. Dingeldein‐Bettler +14 more
Based on the Swiss Pediatric Oncology Group (SPOG) cancer registry data during 1981-1991, a high average incidence of 8 new NHL per million children younger than 15 years per year was found.
CA A Cancer Journal for CliniciansChildhood Cancer: Patterns of Protocol Participation in a National Survey
54 Citations2001Stephen J. Shochat, Amy M. Fremgen +7 more
As improved survival rates have been reported for pediatric cancer patients who are treated on controlled clinical trials, it is important to understand the national utilization of such protocols.
CancerReferral patterns of childhood brain tumors in the state of connecticut
42 Citations1982Patricia K. Duffner, Michael E. Cohen +1 more
Analysis of data from the Connecticut Tumor Registry suggested that children with certain types of brain tumors may fare better when treated at university cancer centers.
PEDIATRICSAnnual Summary of Vital Statistics—1993
27 Citations1994Myron E. Wegman
A new low in the infant mortality rate was reached again in 1993, at 828.8 deaths per 100,000 live births, a decline of 2% from 848.7 in 1992, and deaths and the death rate both increased and, more significantly, the age-adjusted death rate increased.
PubMedPathologic evaluation of pediatric soft tissue tumors.
25 Citations1998Cheryl M. Coffin, Louis P. Dehner
It is important for the pathologist and other members of the multidisciplinary health care team to remember that a soft tissue tumor in a child may have genetic implications that directly influence the care of the patient and the family and for which the excised tissue offers a potentially invaluable resource for future studies.
Seminars in HematologyMolecular monitoring of hematologic malignancies: Current and future issues
13 Citations2002Francesco Lo‐Coco, Silvia De Santis +3 more
In patients with APL, RT-PCR is now being used to detect molecular relapse, and a strong association has been found between outcome and the treatment of molecular as opposed to hematologic relapse.